CN104523870A - Traditional Chinese medicine composition for treating pachynsis pleurae caused by tuberculous pleuritis - Google Patents

Traditional Chinese medicine composition for treating pachynsis pleurae caused by tuberculous pleuritis Download PDF

Info

Publication number
CN104523870A
CN104523870A CN201410785697.8A CN201410785697A CN104523870A CN 104523870 A CN104523870 A CN 104523870A CN 201410785697 A CN201410785697 A CN 201410785697A CN 104523870 A CN104523870 A CN 104523870A
Authority
CN
China
Prior art keywords
chinese medicine
medicine composition
caused
traditional chinese
tuberculous pleuritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410785697.8A
Other languages
Chinese (zh)
Inventor
冷洁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410785697.8A priority Critical patent/CN104523870A/en
Publication of CN104523870A publication Critical patent/CN104523870A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating pachynsis pleurae caused by tuberculous pleuritis. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: radix aconite, asarum and the like; wherein all the raw materials account for 50%-80%; the added adjuvant accounts for 20%-50%; the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: radix aconite, asarum and the like; the radix aconite, asarum and cassia twig account for 50%-80%; and the added adjuvant accounts for 20%-50%. Compared with the prior art, the traditional Chinese medicine composition has the beneficial effects that due to the adoption of the traditional Chinese medicine theories of 'warming and activating meridians, inducing diuresis, and removing dampness', and the method of 'treating an internal illness by external treatment', the pachynsis pleurae caused by tuberculous pleuritis can be thoroughly cured once and for all or alleviated; and the traditional Chinese medicine composition has the advantages of no operation, no pain, no side effect, low price and the like.

Description

A kind of Chinese medicine composition for the treatment of pachynsis pleurae caused by tuberculous pleuritis
The application is divisional application, and the applying date of original application is on November 26th, 2014, and application number is 201410689152.7, and invention and created name is " a kind of Chinese medicine composition and Therapeutic Method thereof for the treatment of pachynsis pleurae caused by tuberculous pleuritis ".
Technical field
The invention belongs to field of medicinal compositions, be specifically related to a kind of Chinese medicine composition for the treatment of pachynsis pleurae caused by tuberculous pleuritis.
Background technology
Pachynsis pleurae caused by tuberculous pleuritis is the pertinacious disease healed compared with refractory at present, the treatment of this disease not in time, light then cause chest tightness sense, pain, time serious, thoracic deformity can be caused, forming fibre board constraint pulmonary function can concurrent offside emphysema, and, cause the possibility of delay lungy or recurrence in addition; Pachynsis pleurae caused by current clinical treatment tuberculous pleuritis, adopts the methods such as whole body therapeutic, Drug therapy and operative treatment to treat mostly; Systemic treatments mainly based on respiratory function exercise, have additional nutrients and health invigorating; Drug treatment is major-minorly wait activating blood and removing stasis drug etc. to treat with river green grass or young crops with antituberculotics; Operative treatment has out again breast pleural decortication, the treatment of thoracoscopic film endarterectomy etc.; Above-mentioned Therapeutic Method all has certain curative effect to the pachynsis pleurae caused by tuberculous pleuritis, but has the shortcomings such as side effect is large, wound large, cost is high, brings huge injury to patient's body and mind.
Summary of the invention
The object of this invention is to provide one and utilize traditional Chinese medical science traditional theory " promoting the flow of QI in the collateral by warming the meridian, diuretic damp eliminating " and " inner disease outer treat " method, can thoroughly effect a radical cure or alleviate caused by tuberculous pleuritis pachynsis pleurae; There is a kind of Chinese medicine composition for the treatment of pachynsis pleurae caused by tuberculous pleuritis not needing operation, no pain, the advantage such as cheap that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of pachynsis pleurae caused by tuberculous pleuritis, it is characterized in that: described Chinese medicine composition is made up of the crude drug of following weight parts: Radix Aconiti, Herba Asari equal portions, accounting is altogether: 50-80%; Adding adjuvant accounting is: 20-50%.
Preferably, described Chinese medicine composition is made up of the crude drug of following weight parts: Radix Aconiti, Herba Asari equal portions, adds Ramulus Cinnamomi, and three kinds of medicine accountings are: 50-80%, adds adjuvant accounting to be: 20-50%.
Preferably, the Radix Aconiti in described Traditional Chinese medicine composition formula, replaces with Radix Aconiti Kusnezoffii.
Preferably, described adjuvant is the 1-3 kind in Poria, Rhizoma Alismatis, Spica Prunellae, Radix cocculi laurifolii, Semen Lepidii (Semen Descurainiae).
The present invention has following features compared to existing technology:
1, the present invention adopts the theory of the traditional Chinese medical science " promoting the flow of QI in the collateral by warming the meridian, diuretic damp eliminating " and " inner disease outer treat ", namely be main with the Chinese herbal medicine of the temperature three-way meridians such as Radix Aconiti, Herba Asari, Ramulus Cinnamomi, be aided with the Chinese herbal medicine such as diuretic damp eliminating such as Poria, Rhizoma Alismatis, Spica Prunellae, Radix cocculi laurifolii, after utilizing medicinal steam fumigation-washing therapy device to be heated by medicine, directly spray infiltration lesions position and surrounding thereof with steam, treat the pachynsis pleurae caused by tuberculous pleuritis with this.
2, the present invention adopts the pachynsis pleurae caused by fumigation therapy tuberculous pleuritis, no pain, do not need operation, do not need to take medicine, do not damage human body.
3, formula of the present invention is simple, and resources of Chinese medicinal herb is enriched, have no side effect, drug availability is high, and effective percentage is up to 95%.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described further:
Embodiment one:
Treat a Chinese medicine composition for the pachynsis pleurae caused by tuberculous pleuritis, its formula proportion percentage component is: Radix Aconiti 25%, Herba Asari 25%, Radix cocculi laurifolii 18%, Spica Prunellae 17%, Poria 15%.Its manufacture method simply mixes after being concocted according to a conventional method by each component in formula.
Embodiment two:
Treat a Chinese medicine composition for the pachynsis pleurae caused by tuberculous pleuritis, its formula proportion percentage component is: Radix Aconiti Kusnezoffii 20%, Herba Asari 20%, Ramulus Cinnamomi 30%, Poria 15%, Rhizoma Alismatis 15%.Preparation method is with example one.
Embodiment three:
Treat a Chinese medicine composition for the pachynsis pleurae caused by tuberculous pleuritis, its formula proportion percentage component is: Radix Aconiti 30%, Herba Asari 30%, Ramulus Cinnamomi 20%, Spica Prunellae 20%.Preparation method is with example one.
Embodiment four:
Treat a Chinese medicine composition for the pachynsis pleurae caused by tuberculous pleuritis, its formula proportion percentage component is: Radix Aconiti 40%, Herba Asari 40%, Rhizoma Alismatis 10%, Semen Lepidii (Semen Descurainiae) 10%.Preparation method is with example one.
Embodiment five:
Treat a Chinese medicine composition for the pachynsis pleurae caused by tuberculous pleuritis, its formula proportion percentage component is: Radix Aconiti 20%, Herba Asari 20%, Ramulus Cinnamomi 20%, Spica Prunellae 20%, Radix cocculi laurifolii 10%, Semen Lepidii (Semen Descurainiae) 10%.Preparation method is with example one.
Embodiment six:
Treat a Chinese medicine composition for the pachynsis pleurae caused by tuberculous pleuritis, its formula proportion percentage component is: Radix Aconiti 20%, Herba Asari 20%, Ramulus Cinnamomi 10%, Rhizoma Alismatis 20%, Spica Prunellae 20%, Semen Lepidii (Semen Descurainiae) 10%.Preparation method is with example one.
Embodiment seven:
Treat a Chinese medicine composition for the pachynsis pleurae caused by tuberculous pleuritis, its formula proportion percentage component is: Radix Aconiti Kusnezoffii 15%, Herba Asari 15%, Ramulus Cinnamomi 25%, Rhizoma Alismatis 15%, Spica Prunellae 15%, Radix cocculi laurifolii 15%.Preparation method is with example one.
Embodiment eight:
Treat a Chinese medicine composition for the pachynsis pleurae caused by tuberculous pleuritis, its formula proportion percentage component is: Radix Aconiti 40%, Herba Asari 40%, Radix cocculi laurifolii 10%, Poria 10%.Preparation method is with example one.
Embodiment nine:
Treat a Chinese medicine composition for the pachynsis pleurae caused by tuberculous pleuritis, its formula proportion percentage component is: Radix Aconiti Kusnezoffii 15%, Herba Asari 15%, Ramulus Cinnamomi 25%, Rhizoma Alismatis 15%, Poria 15%, Radix cocculi laurifolii 15%.Preparation method is with example one.
Embodiment ten:
Treat a Chinese medicine composition for the pachynsis pleurae caused by tuberculous pleuritis, its formula proportion percentage component is: Radix Aconiti 30%, Herba Asari 30%, Ramulus Cinnamomi 20%, Rhizoma Alismatis 10%, Radix cocculi laurifolii 10%.Preparation method is with example one.
The present invention treats method and the points for attention of the pachynsis pleurae caused by tuberculous pleuritis:
1, the present invention is not suitable for deficiency of YIN weakling application in infant and old people.
2, patient first should make a definite diagnosis before the treatment and can treat, as thoracic deformity appears in patient in therapeutic process, and Ying Qu hospital row pleural decortication.
3, during treatment, after each component can being taken by the weight percentage of formula, (without sequencing) is mixed; Add in steam fumigator, after add 500ml-800ml water, to steam fumigator heating, produce after steam and spray to affected area surrounding skin.
4, should by the proportion shared by the selection such as the order of severity of patient chest pachyhymenia, focus scope medicine, dosage and each component during treatment.The patient that general early stage pachynsis pleurae is light, focus scope is little, dosage should be little, and middle and advanced stage dosage should be large, general mid-term dosage be early stage 1.5-2 doubly, should be the 1.5-2 in mid-term late period doubly; Component shared by early stage principal agent reduces relatively, and the component shared by middle and advanced stage principal agent increases relatively, and general early stage principal agent accounts for 50%-60%, and mid-term, principal agent accounted for 60%-70%, and late period accounts for 70%-80%.During early stage patient treatment, smoke treatment after 1 week with early stage dosage, if without exception, sustainable smoked treatment 6 months; Mid-term, patient first can smoke treatment 1 week with early stage dosage, if without exception, smoked treatment 1 week again with the dosage in mid-term, if still without exception, treated to 6 months so that dosage in mid-term is smoked; Patients with terminal, first smokes 1 week with early stage dosage, if without exception, smokes treatment 1 week with dosage in late period, if still without exception, treats to 6 months so that dosage in late period is smoked.Once, each smoking treats half an hour to the every day of each smoked treatment sooner or later.Junior middle school's treatment of late stage time is about 6 months.
The pachynsis pleurae effect of its treatment caused by tuberculous pleuritis is shown in following example:
Example one:
Open xx, man, 38 years old, clinical diagnosis was: tuberculous pleuritis causes pachynsis pleurae, and symptom is evident as master with chest tightness sense, gave the blue or green quiet treatment in river invalid for January, gave smoked treatment recovery from illness half a year.
Example two:
Yan xx, female, 25 years old, clinical diagnosis was: tuberculous pleuritis causes pachynsis pleurae, and symptom, based on chest pain, gives Treatment of Spantaneous not thorough, gave smoked treatment recovery from illness in 5 months.
Example three:
Soviet Union xx, man, 35 years old, clinical diagnosis was: tuberculous pleuritis causes pachynsis pleurae, and symptom, based on cough, with chest pain, to give in thoracic cavity urokinase injection 2 weeks, poor effect, gave fumigation therapy and fully recovered half a year.
Example four:
King xx, man, 50 years old, clinical diagnosis was: tuberculous pleuritis causes pachynsis pleurae, and symptom is based on dyspnea, and surgery suggestion corrective surgery, patient refuses, and gives the recovery from illness of fumigation therapy first quarter moon.
The above is only preferred embodiment of the present invention, and be not restriction the present invention being made to other form, any those skilled in the art may utilize the technology contents of above-mentioned announcement to be changed or be modified as the Equivalent embodiments of equivalent variations.But everyly do not depart from technical solution of the present invention content, any simple modification, equivalent variations and the remodeling done above embodiment according to technical spirit of the present invention, still belong to the protection domain of technical solution of the present invention.

Claims (4)

1. treat a Chinese medicine composition for the pachynsis pleurae caused by tuberculous pleuritis, it is characterized in that: described Chinese medicine composition is made up of the crude drug of following weight parts: Radix Aconiti, Herba Asari equal portions, accounting is altogether: 50-80%; Adding adjuvant accounting is: 20-50%.
2. the Chinese medicine composition of the pachynsis pleurae caused by treatment tuberculous pleuritis according to claim 1, it is characterized in that: described Chinese medicine composition is made up of the crude drug of following weight parts: Radix Aconiti, Herba Asari equal portions, add Ramulus Cinnamomi, three kinds of medicine accountings are: 50-80%, add adjuvant accounting to be: 20-50%.
3. the Chinese medicine composition of the pachynsis pleurae caused by treatment tuberculous pleuritis according to claim 1 and 2, is characterized in that: the Radix Aconiti in described Traditional Chinese medicine composition formula, replaces with Radix Aconiti Kusnezoffii.
4. the Chinese medicine composition of the pachynsis pleurae caused by treatment tuberculous pleuritis according to claim 3, is characterized in that: described adjuvant is the 1-3 kind in Poria, Rhizoma Alismatis, Spica Prunellae, Radix cocculi laurifolii, Semen Lepidii (Semen Descurainiae).
CN201410785697.8A 2014-12-18 2014-12-18 Traditional Chinese medicine composition for treating pachynsis pleurae caused by tuberculous pleuritis Pending CN104523870A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410785697.8A CN104523870A (en) 2014-12-18 2014-12-18 Traditional Chinese medicine composition for treating pachynsis pleurae caused by tuberculous pleuritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410785697.8A CN104523870A (en) 2014-12-18 2014-12-18 Traditional Chinese medicine composition for treating pachynsis pleurae caused by tuberculous pleuritis

Publications (1)

Publication Number Publication Date
CN104523870A true CN104523870A (en) 2015-04-22

Family

ID=52839626

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410785697.8A Pending CN104523870A (en) 2014-12-18 2014-12-18 Traditional Chinese medicine composition for treating pachynsis pleurae caused by tuberculous pleuritis

Country Status (1)

Country Link
CN (1) CN104523870A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103655766A (en) * 2012-09-20 2014-03-26 四川大学华西医院 Traditional Chinese medicine anesthetic extract and preparation method and application thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103655766A (en) * 2012-09-20 2014-03-26 四川大学华西医院 Traditional Chinese medicine anesthetic extract and preparation method and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
韦绪性: "《中医痛证诊疗大全》", 30 November 1992, 中国中医药出版社 *
魏玉香: "《妙方奇穴百病康复》", 30 April 2011, 中国中医药出版社 *

Similar Documents

Publication Publication Date Title
CN101264146A (en) Externally-applied Chinese herbal medicine for treating muscle and joint disease and preparation thereof
CN103768315A (en) Bone-setting plaster for setting bone and activating blood circulation
CN102475868B (en) Anti-rheumatism medicinal liquor
CN102872301B (en) Anti-rheumatism medicinal liquor and using method thereof
CN103550479B (en) A kind of topical composition for the treatment of rheumatalgia
CN102755622A (en) Medicine for treating rheumatoid arthritis
CN105477484A (en) Medicine for treating allergic asthma
CN104042698A (en) Fire treatment liquid
CN107582702A (en) Medicine Wax composition for traditional Chinese medical science wax therapy and preparation method thereof
CN103330798A (en) Traditional Chinese medicinal preparation for treating rheumatisms
CN103230535A (en) Medicinal liquor with function of activating collaterals to ease pain
CN103301430A (en) Medicament for treating hyperostosis and pain in waist and lower extremities and preparation method thereof
CN103157006B (en) Oral traditional Chinese medicine formula for treating osteoarthritis
CN102258602B (en) Chinese medicinal composition for treating rheumatism and rheumatoid and preparation method thereof
CN102416105B (en) Third-degree burn and scald repair ointment
CN104758525A (en) Traditional Chinese medicine composition for treating primary dysmenorrhea in the type of cold-dampness coagulation
CN104523870A (en) Traditional Chinese medicine composition for treating pachynsis pleurae caused by tuberculous pleuritis
CN103751454A (en) Traditional Chinese medicine for treating rheumatism
CN103623263A (en) Compound traditional Chinese medicine for treating tinea corporis
CN104435183A (en) Use method of traditional Chinese medicine composition for treating pachynsis pleurae
CN103690621A (en) Traditional Chinese medicine decoction for treating scapulohumeral periarthritis
CN103961434B (en) A kind of fracture surgery Chinese medicine composition
CN106361840A (en) Traditional Chinese medicine composite used for treating rheumatism and preparing method thereof
CN106110215A (en) A kind of medicine treating varicose veins of the lower extremity
CN105288158A (en) Traditional Chinese medicine for treatment of cold-dampness type chronic rhinitis

Legal Events

Date Code Title Description
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150422

RJ01 Rejection of invention patent application after publication